News

Thursday November 26, 2020

26 Nov 2020 – Destiny Pharma – Result of General Meeting and Total Voting Rights

Destiny Pharma announces that, at the General Meeting held earlier today, all resolutions were duly passed by shareholders on a poll. For full press release, please click on link below:- […]

Wednesday November 25, 2020

25 Nov 2020 – Destiny Pharma announces total gross proceeds raised via Open Offer

Destiny Pharma announces that it has conditionally raised total gross proceeds of approximately £0.87m through the Open Offer which was announced on 9 November 2020. This is in addition to […]

Wednesday November 18, 2020

18 Nov 2020 – Antibiotic Resistance: A Matter of Time – FT

A video, published on the first day of WHO’s World Antimicrobial (#AMR) Awareness Week by FT, highlights the threat of #AMR.  To view the video, please click on the link […]

Friday November 13, 2020

Note to shareholders

Please note the following in relation to the upcoming General Meeting on 26 November 2020: (i) the entitlement time and date is 18:30 p.m. on 24 November 2020 (please ignore […]

Wednesday November 11, 2020

Circular to shareholders dated 10 November 2020

Circular to shareholders dated 10 November 2020

Wednesday November 11, 2020

Open Offer Application Form

Open Offer Application Form

Monday November 9, 2020

09 Nov 2020 – Destiny Pharma to acquire Phase 3 ready C.difficile program and announce...

Destiny Pharma to acquire Phase 3 ready C.difficile program and announces fund raising.  For full release please press here

Monday November 9, 2020

09 Nov 2020 – Destiny Pharma to acquire Phase 3 ready C.difficile program and announce...

Destiny Pharma to acquire Phase 3 ready C.difficile program and announces fund raising.  For full release please press here